Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

489 public trials 92 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Completed

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, +33 more
Locations
  • Lucile Packard Children's Hospital, Stanford Palo Alto, California, United States
  • National Cancer Institute, Center for Cancer Research Bethesda, Maryland, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Completed

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

NCT02452554

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +45 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 69 locations
View Trial Details
Completed

Oral Liquid 13-cis-retinoic Acid (13-CRA)

NCT03291080

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Bruce Morland Birmingham, United Kingdom
  • Dr Antony Ng Bristol, United Kingdom
  • Dr Amos Burke Cambridge, United Kingdom
  • Mark Brougham Edinburgh, United Kingdom
View Trial Details
Completed

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

NCT02124772

Conditions
Cancer, Hemic and Lymphatic Diseases, Histiocytosis, +23 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
  • Novartis Investigative Site Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Completed

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma

NCT00499616

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 189 locations
View Trial Details

Related conditions